Home › Core › ISCC-IDs › 28CC2reKmJttH

View ISCC-ID

Core Data

28CC2reKmJttH
ISCC-ID - digital asset identifier
CCBJBCdqYpHuc-CT5mEKRSkgsss-CDC9jtjsZNw3b-CRbTceHxFrDM2
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

antikoagulation bei vorhofflimmern dabigatran rivaroxaban oder apixaban die qual der wahl

Ledger Reference

coblo
Source Ledger/Blockchain
3167
N-th ISCC Decleration on source ledger
2c3d5c3c8e77154fb331d996bfde632564f74a044889e0ffcc2c0cc4aea3debd
Hash of block that includes the ISCC-DECLARATION
f275b90089d7016b30f613969906ca35b1c3a7a039f6eae1db03cfb53277fc5f
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Antikoagulation bei Vorhofflimmern - Dabigatran, Rivaroxaban oder Apixaban - die Qual der Wahl?", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Armin Luik", "@type": "Person"}, {"name": "Claus Schmitt", "@type": "Person"}, {"name": "Andrea Radzewitz", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0033-1353586.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Thieme Publishing Group", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1055/s-0033-1353586", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCBJBCdqYpHuc-CT5mEKRSkgsss-CDC9jtjsZNw3b-CRbTceHxFrDM2", "propertyID": "ISCC"}], "datePublished": "2013-09-18"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close